- Common shares of Pangea Natural Foods (PNGA) began trading today on the CSE
- The company produces and sells veggie and pea-protein-based patties free of GMO ingredients, fillers, antibiotics, hormones and bioengineered ingredients
- A major focus includes expanding its North American distribution network
- Pangea Natural Foods is a food manufacturing company focused on plant-based products for the North American market
- Pangea Natural Foods (PNGA) is down by 20 per cent trading at $0.12 per share
Common shares of Pangea Natural Foods (PNGA) began trading today on the CSE.
It produces and sells veggie and pea-protein-based patties free of GMO ingredients, fillers, antibiotics, hormones and bioengineered ingredients.
Products are available via e-commerce platforms and physical retail outlets.
The company’s Vancouver production facility is approved by both the Canadian Food Inspection Agency and the U.S. Food and Drug Administration.
“Pangea Natural Foods has partnered with experienced food scientists to formulate its products, with a focus on delivering high-quality food products to consumers,” stated Pratap Sandhu, Pangea’s CEO. “We look forward to introducing our products to a broad range of customers and widening our products’ distribution throughout North America. We truly believe our loyal customers speak for themselves.”
Pangea Natural Foods is a food manufacturing company focused on plant-based products for the North American market.
Pangea Natural Foods (PNGA) is down by 20 per cent trading at $0.12 per share as of 11:36 am EST.
